Matthew Meyerson Selected Research

Matthew Meyerson Research Topics

Disease

163	Neoplasms (Cancer) 02/2024 - 12/2002
38	Lung Neoplasms (Lung Cancer) 03/2024 - 02/2004
29	Adenocarcinoma of Lung 10/2023 - 12/2002
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2004
18	Carcinogenesis 12/2023 - 10/2005
13	Carcinoma (Carcinomatosis) 12/2023 - 05/2004
11	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2008
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 05/2006
9	Adenocarcinoma 03/2018 - 10/2004
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2003
8	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2007
6	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 12/2006
6	Leukemia 01/2019 - 01/2005
6	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 02/2008
5	Melanoma (Melanoma, Malignant) 01/2022 - 12/2002
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 12/2017
4	Disease Progression 10/2021 - 03/2007
4	Ovarian Neoplasms (Ovarian Cancer) 11/2019 - 02/2009
4	Glioma (Gliomas) 01/2018 - 12/2006
4	Colonic Neoplasms (Colon Cancer) 12/2017 - 09/2008
4	Medulloblastoma 08/2012 - 04/2011
4	Neuroblastoma 10/2008 - 12/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014 - 03/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 07/2023
2	Infections 01/2020 - 10/2010
2	Neoplasm Metastasis (Metastasis) 11/2018 - 11/2015
2	Multiple Myeloma 01/2018 - 03/2011
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 11/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 09/2014
2	Brain Neoplasms (Brain Tumor) 11/2015 - 03/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2015 - 09/2004
2	Chromothripsis 06/2015 - 08/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2014 - 06/2014
2	Multiple Endocrine Neoplasia Type 1 08/2011 - 02/2004

Drug/Important Bio-Agent (IBA)

46	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2004
30	ErbB Receptors (EGF Receptor)IBA 03/2024 - 06/2004
27	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2005
26	Phosphotransferases (Kinase)IBA 01/2022 - 06/2004
14	RNA (Ribonucleic Acid)IBA 02/2023 - 01/2005
13	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2021 - 09/2004
13	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 11/2005
13	Gefitinib (Iressa)FDA Link 07/2008 - 06/2004
11	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2004
11	Transcription Factors (Transcription Factor)IBA 10/2023 - 12/2007
11	Messenger RNA (mRNA)IBA 01/2018 - 05/2005
10	Tyrosine Kinase InhibitorsIBA 04/2021 - 05/2006
8	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 10/2005
7	ChromatinIBA 01/2023 - 01/2009
7	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 06/2004
6	Hormones (Hormone)IBA 01/2022 - 09/2006
6	NucleotidesIBA 01/2021 - 08/2003
6	ParaffinIBA 03/2018 - 02/2006
6	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2008
6	Histone MethyltransferasesIBA 08/2012 - 02/2004
5	MicroRNAs (MicroRNA)IBA 12/2018 - 07/2009
5	Histones (Histone)IBA 01/2016 - 02/2004
4	InterferonsIBA 02/2024 - 01/2020
4	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 01/2023 - 02/2016
4	LigandsIBA 01/2023 - 10/2005
4	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 10/2005
4	Cell-Free Nucleic AcidsIBA 01/2020 - 11/2017
4	Formaldehyde (Formol)FDA Link 03/2018 - 02/2006
4	CateninsIBA 01/2018 - 09/2011
4	Dasatinib (BMS 354825)FDA Link 10/2015 - 06/2009
4	OligonucleotidesIBA 02/2009 - 02/2004
3	CytokinesIBA 05/2024 - 12/2013
3	Trastuzumab (Herceptin)FDA Link 04/2024 - 02/2008
3	6- (4- (diethylamino)- 3- nitrophenyl)- 5- methyl- 4,5- dihydropyridazin- 3(2H)- oneIBA 01/2020 - 02/2016
3	CrizotinibIBA 01/2019 - 03/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 12/2016
3	Sirolimus (Rapamycin)FDA Link 05/2013 - 12/2008
2	dacomitinibIBA 03/2024 - 12/2007
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2024 - 08/2023
2	ExoribonucleasesIBA 01/2024 - 08/2023
2	Protein Kinases (Protein Kinase)IBA 01/2024 - 08/2023
2	DNA Transposable Elements (Element, IS)IBA 12/2023 - 03/2023
2	Tumor Biomarkers (Tumor Markers)IBA 12/2023 - 03/2023
2	NucleophosminIBA 12/2023 - 07/2023
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2023 - 12/2021
2	Phenobarbital (Luminal)FDA Link 01/2023 - 11/2022
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2022 - 12/2017
2	Adenosine DeaminaseIBA 04/2022 - 12/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 05/2012
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021 - 11/2019
2	PlatinumIBA 11/2019 - 02/2009
2	Circulating Tumor DNAIBA 01/2019 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 03/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 01/2018
2	SmokeIBA 11/2015 - 01/2014
2	Discoidin Domain Receptor 2IBA 10/2015 - 06/2011
2	Cetuximab (Erbitux)FDA Link 06/2014 - 11/2013
2	Amino Acids FDA Link 05/2013 - 02/2005
2	Lysine (L-Lysine)FDA Link 08/2011 - 02/2004
2	Antineoplastic Agents (Antineoplastics)IBA 08/2011 - 12/2004
2	Serine (L-Serine)FDA Link 07/2011 - 03/2006
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2011 - 02/2008

Therapy/Procedure

66	Therapeutics 02/2024 - 06/2004
6	Drug Therapy (Chemotherapy) 11/2019 - 12/2002
3	Castration 01/2022 - 11/2018